Cargando…
Biophysical characterisation of the Bcl-x pre-mRNA and binding specificity of the ellipticine derivative GQC-05: Implication for alternative splicing regulation
The BCL2L1 gene expresses two isoforms of Bcl-x protein via the use of either of two alternative 5′ splice sites (5′ss) in exon 2. These proteins have antagonistic actions, Bcl-X(L) being anti-apoptotic and Bcl-X(S) pro-apoptotic. In a number of cancers the Bcl-X(L) isoform is over-expressed, result...
Autores principales: | Bhogadia, Mohammed, Stone, Beth, Del Villar Guerra, Rafael, Muskett, Frederick W., Ghosh, Sudipta, Taladriz-Sender, Andrea, Burley, Glenn A., Eperon, Ian C., Hudson, Andrew J., Dominguez, Cyril |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428248/ https://www.ncbi.nlm.nih.gov/pubmed/36060245 http://dx.doi.org/10.3389/fmolb.2022.943105 |
Ejemplares similares
-
Contemporary biophysical approaches for studying 14-3-3 protein-protein interactions
por: Thurairajah, Bethany, et al.
Publicado: (2022) -
Pharmacokinetics of Peptide Mediated Delivery of Anticancer Drug Ellipticine
por: Ma, Weina, et al.
Publicado: (2012) -
Editorial: Biophysics of co-translational protein folding
por: Fried, Stephen D., et al.
Publicado: (2022) -
Ellipticine cytotoxicity to cancer cell lines — a comparative study
por: Stiborová, Marie, et al.
Publicado: (2011) -
Synthesis and Evaluation of Novel Ellipticines and Derivatives as Inhibitors of Phytophthora infestans
por: McKee, Mary L., et al.
Publicado: (2020)